Sir Charles Gairdner Hospital
20
3
3
9
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 50/100
15.0%
3 terminated/withdrawn out of 20 trials
75.0%
-11.5% vs industry average
25%
5 trials in Phase 3/4
22%
2 of 9 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (20)
AMPLE-3: IPC Plus Talc vs VATS in Management of Malignant Pleural Effusion
Role: collaborator
Evaluating Ovarian Toxicity Outcomes Following Immunotherapy in Patients With Triple-Negative Breast Cancer (TNBC)
Role: collaborator
Treatable Traits in Interstitial Lung Disease
Role: collaborator
Investigating Visual Verticality Disorder and Lateropulsion in a Neurosurgical Cohort of Patients With Brain Tumours
Role: collaborator
A Prospective, Multi-Centre Trial of TKI Redifferentiation Therapy in Patients With RAIR Thyroid Cancer (I-FIRST Study)
Role: collaborator
Polysomnographic Titration of Non-invasive Ventilation in Motor Neurone Disease
Role: collaborator
The Safety and Tolerability of Intra-abdominal t-PA and DNase on Peritonitis in Peritoneal Dialysis Patients
Role: lead
Juno Perth Clinical Trial
Role: collaborator
Optimising Anterior Pallidal Deep Brain Stimulation for Tourette's Syndrome
Role: collaborator
Midodrine for the Treatment of Refractory Hypotension
Role: collaborator
Safety and Clinical Effectiveness of Pipeline™ Shield Devices for Intracranial Aneurysms
Role: collaborator
Topical Magnesium and Muscle Cramps in Dialysis Patients.
Role: lead
Phase I Study of the Volitinib (HMPL-504) in Patients With Advanced Solid Tumors
Role: collaborator
Catheter Over Needle vs Catheter Through Needle
Role: lead
An Australian Study of Mesenchymal Stromal Cells for Crohn's Disease
Role: collaborator
Exercise Training in Patients With Non-cystic Fibrosis (CF) Bronchiectasis
Role: collaborator
Effect of 25-hydroxyvitamin D and a Structured Exercise Program on Dialysis Patients
Role: lead
Audit of the Effect of Changing From IV to SC Administration of ESA's in Haemodialysis Patients
Role: lead
Short Term Effects of FX Dialysers on QOL and Inflammation
Role: lead
Thyroxine Titration Study
Role: lead
All 20 trials loaded